Management of pharmacovigilance in clinical trials: the example of an academic system

被引：0
|
作者：
Chiffoleau, A.
Royer-Moes, A.
Lebigre, M.
Omnes, A.
Jolliet, P.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
532
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] Pharmacovigilance and clinical trials: Experience of a French pharmacovigilance department
    Brocvielle, H.
    Thomas, L.
    Le Louet, H.
    [J]. DRUG SAFETY, 2007, 30 (10) : 962 - 963
  • [2] Consolidated trial management: an example of a purpose built clinical trial management system for an academic research organization
    Mister, Rebecca
    Atluri, Seshu
    Vachan, Burcu
    Hague, Wendy
    [J]. TRIALS, 2017, 18
  • [3] Pharmacovigilance in clinical trials: a tremendous change
    Bertram, D.
    Plattner, V.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 63 - 63
  • [4] Pharmacovigilance and Pharmacoeconomics: The Burden of Pharmacovigilance on the Health System, Rheumatoid Arthritis as an Example
    Papadopoulos, G.
    Demetzos, K.
    Markantoni-Kyroudi, S.
    Souliotis, K.
    [J]. DRUG SAFETY, 2015, 38 (10) : 944 - 944
  • [5] Compliance Oriented Process Management Using the Example of Clinical Trials
    Schlundt, Joerg
    Jablonski, Stefan
    [J]. BUSINESS PROCESS MANAGEMENT WORKSHOPS, PT II, 2012, 100 : 212 - +
  • [6] The Role of Systematic Reviews in Pharmacovigilance Planning and Clinical Trials Authorisation Application: Example from the SLEEPS Trial
    Gamble, Carrol
    Wolf, Andrew
    Sinha, Ian
    Spowart, Catherine
    Williamson, Paula
    [J]. PLOS ONE, 2013, 8 (03):
  • [7] Pharmacovigilance in Clinical Trials: Current Practice and Challenges
    Cheaib, N.
    [J]. ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE, 2016, 23 (01): : 23 - 30
  • [8] PRESCRIBING AT THE END OF LIFE, PHARMACOVIGILANCE AND CLINICAL TRIALS
    Rowett, D.
    Currow, D.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 : 6 - 6
  • [9] Pharmacovigilance in European clinical trials: Duties of sponsor
    Bertram, D.
    Plattner, V.
    [J]. DRUG SAFETY, 2007, 30 (10) : 936 - 936
  • [10] Guideline for optimization of the pharmacovigilance of the radiopharmaceutical in clinical trials
    Chiffoleau, A.
    Coacolo, C.
    Scotet-Cerato, E.
    Moulazem, H.
    Jobert, A.
    Faivre-Chauvet, A.
    Merouze, C.
    Omnes, A.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 20 - 21
12345